Mainz Biomed NV (Mainz Biomed NV) Additional Paid-In Capital : $51.51 Mil(As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Additional Paid-In Capital?

Mainz Biomed NV's quarterly additional paid-in capital increased from Jun. 2023 ($43.21 Mil) to Sep. 2023 ($46.53 Mil) and increased from Sep. 2023 ($46.53 Mil) to Dec. 2023 ($51.51 Mil).

Mainz Biomed NV's annual additional paid-in capital increased from Dec. 2021 ($13.13 Mil) to Dec. 2022 ($38.83 Mil) and increased from Dec. 2022 ($38.83 Mil) to Dec. 2023 ($51.51 Mil).

Mainz Biomed NV Additional Paid-In Capital Historical Data

The historical data trend for Mainz Biomed NV's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Additional Paid-In Capital Chart

Mainz Biomed NV Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

0.04

13.13

38.83

51.51

Mainz Biomed NV Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial								38.83	40.13	43.21	46.53	51.51

Mainz Biomed NV Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Mainz Biomed NV Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Mainz Biomed NV (Mainz Biomed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

4TO:Germany

Address

Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129

Website

https://www.mainzbiomed.com

Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.